You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thyroid ophthalmopathy

Showing 1 - 25 of 1,616
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)

Recruiting
  • Tocilizumab
  • Thyroid Associated Ophthalmopathy
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Oct 11, 2023

Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Miami, Morgantown (linsitinib)

Recruiting
  • Thyroid Eye Disease
  • +11 more
  • Miami, Florida
  • +1 more
Oct 31, 2023

Thyroid Eye Disease Trial (Satralizumab, Placebo)

Not yet recruiting
  • Thyroid Eye Disease
  • (no location specified)
Oct 25, 2023

Thyroid Eye Disease Trial (Satralizumab, Placebo)

Not yet recruiting
  • Thyroid Eye Disease
  • (no location specified)
Aug 4, 2023

Thyroid Eye Disease, TED Trial in Shanghai (IBI311)

Recruiting
  • Thyroid Eye Disease, TED
  • Shanghai, Shanghai, China
    Ninth People's Hospital Affiliated to Shanghai Jiao Tong Univers
Nov 9, 2023

Thyroid Eye Disease Trial in Miami (TOUR006 - 20 MG, Placebo, TOUR006 - 50 MG)

Recruiting
  • Thyroid Eye Disease
  • TOUR006 - 20 MG
  • +2 more
  • Miami, Florida
    Site - 0103
Oct 11, 2023

Customized Multiple Orbital Wall Decompression for

Recruiting
  • Thyroid Eye Disease
  • Modified multiple orbital wall decompression
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Nov 17, 2022

Thyroid Ophthalmopathy Trial in Shanghai (HBM9161 680 mg qw by q2w from week 13, Placebo, HBM9161 680 mg qw by q2w from week 7)

Recruiting
  • Thyroid Ophthalmopathy
  • HBM9161 680 mg qw by q2w from week 13
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital, Shanghai Jiaotong University S
Feb 22, 2022

Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)

Not yet recruiting
  • Thyroid Eye Disease
  • VRDN-001 10 mg/kg Drug:
  • (no location specified)
Sep 7, 2023

Associated With Mental Fatigue in Graves' Disease

Recruiting
  • Graves Disease
  • +4 more
    • Gothenburg, Sweden
      Department of Endocrinology, Sahlgrenska University Hospital
    Jan 4, 2023

    Thyroid Eye Disease Trial in Beijing (ZB001 for injection)

    Not yet recruiting
    • Thyroid Eye Disease
    • ZB001 for injection
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Mar 7, 2023

    Thyroid Eye Disease Trial in Shanghai (IBI311, )

    Recruiting
    • Thyroid Eye Disease
    • IBI311
    • placebo
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hospital, Shanghai JiaoTong University S
    Mar 20, 2023

    Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy Trial in Guangzhou (Doxycycline hyclate, Placebo)

    Recruiting
    • Graves Ophthalmopathy
    • +8 more
    • Doxycycline hyclate
    • Placebo
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    Nov 16, 2021

    Thyroid Associated Ophthalmopathy Trial in Guangzhou (Doxycycline Hyclate)

    Recruiting
    • Thyroid Associated Ophthalmopathy
    • Doxycycline Hyclate
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    Nov 7, 2021

    Thyroid Associated Ophthalmopathy Trial in Guangzhou (immunosuppressive agent)

    Recruiting
    • Thyroid Associated Ophthalmopathy
    • immunosuppressive agent
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center
    Nov 7, 2021

    Clinical Activity of TAO Using Periocular Images Taken by

    Completed
    • Thyroid Eye Disease
    • taking periorbital selfie images using smartphones
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
      Seoul National University Bundang Hospital
    Feb 15, 2023

    Graves Ophthalmopathy, Thyroid Associated Ophthalmopathy, Thyroid Associated Orbitopathy Trial in Malmö (Simvastatin 40mg)

    Recruiting
    • Graves Ophthalmopathy
    • +2 more
    • Simvastatin 40mg
    • Malmö, Sweden
      Dpt. of Endocrinology, SUS Malmö
    Nov 17, 2021

    Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)

    Not yet recruiting
    • Thyroid-Associated Ophthalmopathy
    • (no location specified)
    Mar 18, 2022

    Thyroid Associated Orbitopathy Trial in Cairo (Methotrexate, Triamcinolone Acetonide)

    Completed
    • Thyroid Associated Orbitopathy
    • Cairo, Egypt
      Cairo University
    Jul 15, 2022

    Thyroid Eye Disease Trial in Beverly Hills, Jacksonville (VB421, Placebo)

    Recruiting
    • Thyroid Eye Disease
    • Beverly Hills, California
    • +1 more
    Jan 12, 2023

    Thyroid Eye Disease, Eyelid Diseases Trial in Tel Hashomer (Tamsulosin)

    Recruiting
    • Thyroid Eye Disease
    • Eyelid Diseases
    • Tel Hashomer, Israel
      Sheba Medical Center
    Jun 22, 2022

    Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,

    Recruiting
    • Thyroid Eye Disease
    • +11 more
    • Beverly Hills, California
    • +22 more
    Jan 30, 2023

    AS-OCT of the Cornea in Thyroid Diseases

    Enrolling by invitation
    • Thyroid Eye Disease
    • AS-OCT
    • Minya, Egypt
    • +1 more
    Feb 14, 2022

    Thyroid Associated Ophthalmopathy Trial in Guangzhou (combination of orbital compression surgery and strabismus surgery, orbital

    Not yet recruiting
    • Thyroid Associated Ophthalmopathy
    • combination of orbital compression surgery and strabismus surgery
    • orbital compression
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center, Sun Yat-sen University
    Jun 6, 2021

    Thyroid Eye Disease, Chronic (Inactive) Thyroid Eye Disease Trial in United States (TEPEZZA, Placebo)

    Active, not recruiting
    • Thyroid Eye Disease
    • Chronic (Inactive) Thyroid Eye Disease
    • TEPEZZA
    • Placebo
    • Beverly Hills, California
    • +11 more
    Nov 4, 2022